Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)
Diseases of the Respiratory Systems | COVID-19 Inpatient
What is the purpose of this trial?
The primary objective of this study is to evaluate the efficacy of 2 remdesivir (RDV) regimens with respect to the normalization of temperature and oxygen saturation through Day 14 in participants with severe coronavirus disease (COVID-19).
- Ages18 years and older
- Trial withGilead Sciences
- Start Date03/20/2020
- End Date06/29/2020
- Last Updated07/17/2020
- Study HIC#2000027732